REQUEST A DEMO
Total
USD $0.00
Search more companies

HLB bioStep Co. Ltd. (South Korea)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences | Medical and Diagnostic Laboratories
Full name: HLB bioStep Co. Ltd. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in non-clinical trial business. The Company operates through three segments. The Non-clinical Test Consignment Agency Business segment conducts non-clinical is mainly engaged in the test on newly developed substances such as new drugs ,and tests the efficacy and pharmacodynamics of substances. In addition, this segment is engaged in the test of the safety of substances. The Bioinfra Business segment is engaged in animal laboratory design, construction, and maintenance. In addition, this segment provides equipment delivery. The Pet Medical Business segment is engaged in the development of veterinary medicine and the sale of companion animal products. The Company was established on Apirl 19, 2012. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on November 27, 2019.

Headquarters
38, Academy-Ro 79Beon-Gil, Yeonsu-Gu
Incheon; Incheon;

Contact Details: Purchase the HLB bioStep Co. Ltd. report to view the information.

Website: http://www.knotus.co.kr

Basic Information
Total Employees:
Purchase the HLB bioStep Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the HLB bioStep Co. Ltd. report to view the information.
Registered Capital:
Purchase the HLB bioStep Co. Ltd. report to view the information.
Financial Auditors:
Purchase the HLB bioStep Co. Ltd. report to view the information.
Incorporation Date:
April 19, 2012
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Company Performance
Financial values in the chart are available after HLB bioStep Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
20.49%
Total operating revenue
20.49%
Operating profit (EBIT)
-34.42%
EBITDA
-17.56%
Net Profit (Loss) for the Period
N/A
Total assets
82.06%
Total equity
5.35%
Operating Profit Margin (ROS)
-8.29%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
111.81%
Quick Ratio
9.85%
Cash Ratio
1.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?